The gold-standard in human subject protection, WCG reviews over 3,000 new protocols and over 15,000 new PIs annually- more than all of our competitors combined. With 11 individual AAHRPP-accredited panels, over 130 experienced board members, and 50 years of experience in protocol and study-related review, WCG brings more expertise to the industry than any other ethical solutions provider.

Our industry clients include all major sponsors, ranging from large pharmaceutical corporations and device manufacturers to small and growing biotechnology companies, as well as the leading contract research organizations (CROs).

We are the chosen partner of over 2,300 of the industry’s leading institutions- including hospitals, research sites, academic medical centers and universities- and proudly serve the premier principal investigators (PIs) in every therapeutic concentration.

Our solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. Today, WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials.

It is our mission to provide our clients with the highest quality of services to accelerate the scientific advancement of human health, while ensuring that the risks of progress never outweigh the value of human life.

Print Friendly, PDF & Email